Patents by Inventor Robert J. Beetel
Robert J. Beetel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11890491Abstract: Various embodiments are directed to a method of driving an end effector coupled to an ultrasonic drive system of a surgical instrument. The method comprises generating at least one electrical signal. The at least one electrical signal is monitored against a first set of logic conditions. A first response is triggered when the first set of logic conditions is met. A parameter is determined from the at least one electrical signal.Type: GrantFiled: June 21, 2019Date of Patent: February 6, 2024Assignee: Cilag GmbH InternationalInventors: Jeffrey D. Messerly, Eitan T. Wiener, Brian T. Noyes, Jeffrey L. Aldridge, James R. Giordano, Robert J. Beetel, III, Daniel J. Abbott, Matthew C. Miller, Aaron C. Voegele, Jeffrey P. Wiley, Nathan J. Price, Daniel W. Price, Robert L. Koch, Jr.
-
Patent number: 11871982Abstract: A control circuit is disclosed that comprises a resistor and a switch network. The switch network is configured to transition between a plurality of states corresponding to a plurality of operational modes of a surgical instrument. In a first phase of a control signal, the control circuit is configured to communicate surgical instrument information to a surgical generator. In the second phase of the control signal and when the at least one switch of the switch network is in a first state of the plurality of states, the control circuit is configured to provide an output corresponding to one of the plurality of states. In the second phase of the control signal and when the at least one switch of the switch network is in a second state of the plurality of states, the control circuit is configured to provide a second output.Type: GrantFiled: July 8, 2021Date of Patent: January 16, 2024Assignee: Cilag GmbH InternationalInventors: Eitan T. Wiener, Jeffrey L. Aldridge, Brian T. Noyes, Jeffrey D. Messerly, James R. Giordano, Robert J. Beetel, III, Nathan J. Price, Matthew C. Miller, Jeffrey P. Wiley, Daniel W. Price, Robert L. Koch, Jr., Joseph A. Brotz, John E. Hein
-
Publication number: 20230082389Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: September 9, 2022Publication date: March 16, 2023Applicant: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Publication number: 20220395323Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: May 25, 2022Publication date: December 15, 2022Applicant: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Patent number: 11471208Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: June 26, 2020Date of Patent: October 18, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Patent number: 11369433Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: December 20, 2018Date of Patent: June 28, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Patent number: 11324543Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: March 26, 2021Date of Patent: May 10, 2022Assignee: Galvanize Therapeutics, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Robert E. Neal, II
-
Patent number: 11213674Abstract: Catheter assemblies for neuromodulation proximate a renal artery bifurcation and associated systems and methods are disclosed herein. A catheter assembly configured in accordance with a particular embodiment of the present technology can include a shaft having a proximal portion, a distal portion, and two therapeutic arms extending from the distal portion. The shaft can be configured to deliver the distal portion to a treatment site proximate a branch point or bifurcation in a renal blood vessel. The therapeutic arms can include energy delivery elements that are configured to deliver the therapeutically-effective energy to renal nerves proximate the branch point.Type: GrantFiled: March 4, 2019Date of Patent: January 4, 2022Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.Inventors: Neil C. Barman, Robert J. Beetel, Benjamin J. Clark, Andrew Wu, Maria G. Aboytes, Denise Zarins
-
Publication number: 20210393314Abstract: A method for determining motional branch current in an ultrasonic transducer of an ultrasonic surgical device over multiple frequencies of a transducer drive signal. The method may comprise, at each of a plurality of frequencies of the transducer drive signal, oversampling a current and voltage of the transducer drive signal, receiving, by a processor, the current and voltage samples, and determining, by the processor, the motional branch current based on the current and voltage samples, a static capacitance of the ultrasonic transducer and the frequency of the transducer drive signal.Type: ApplicationFiled: July 8, 2021Publication date: December 23, 2021Inventors: Eitan T. Wiener, Jeffrey L. Aldridge, Brian T. Noyes, Jeffrey D. Messerly, James R. Giordano, Robert J. Beetel, III, Nathan J. Price, Matthew C. Miller, Jeffrey P. Wiley, Daniel W. Price, Robert L. Koch, Jr., Joseph A. Brotz, John E. Hein
-
Publication number: 20210259760Abstract: The present disclosure relates to devices, systems and methods for evaluating the success of a treatment applied to tissue in a patient, such as a radio frequency ablative treatment used to neuromodulate nerves associated with the renal artery. A system monitors parameters or values generated during the course of a treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of the likelihood that a completed treatment was technically successful. In other embodiments, parameters or values generated during the course of an incomplete treatment (such as due to high temperature or high impedance conditions) may be evaluated to provide additional instructions or feedback to an operator.Type: ApplicationFiled: May 7, 2021Publication date: August 26, 2021Inventors: Sowmya Ballakur, Robert J. Beetel, Paul Friedrichs, David Herzfeld, Andrew Wu, Denise Zarins, Mark S. Leung
-
Patent number: 11090104Abstract: A control circuit configured to receive a control signal that defines a first phase and a second phase from a surgical generator. The control circuit may include a first resistor, a second resistor in parallel with the first resistor, and a switch in series with the second resistor. The switch may be configured to transition between an open state and a closed state corresponding to an operational mode of a surgical instrument. In the first phase of the control signal, the control circuit is configured to communicate surgical instrument information to the surgical generator. In the second phase of the control signal and in the open state of the switch, the control circuit is configured to provide a first output. In the second phase of the control signal and in the closed state of the switch, the control circuit is configured to provide a second output.Type: GrantFiled: January 15, 2019Date of Patent: August 17, 2021Assignee: Cilag GmbH InternationalInventors: Eitan T. Wiener, Jeffrey L. Aldridge, Brian T. Noyes, Jeffrey D. Messerly, James R. Giordano, Robert J. Beetel, III, Nathan J. Price, Matthew C. Miller, Jeffrey P. Wiley, Daniel W. Price, Robert L. Koch, Jr., Joseph A. Brotz, John E. Hein
-
Publication number: 20210236816Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: March 26, 2021Publication date: August 5, 2021Applicant: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long, Robert E. Neal, II
-
Publication number: 20210236815Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, those within the respiratory tract, particularly the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The systems may be used to treat pathogens, such as bacteria and viruses, particularly coronaviruses.Type: ApplicationFiled: March 25, 2021Publication date: August 5, 2021Applicant: Galary, Inc.Inventors: Jonathan R. Waldstreicher, William S. Krimsky, Robert E. Neal, II, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20210146126Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: June 26, 2020Publication date: May 20, 2021Applicant: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long, Robert E. Neal, II
-
Patent number: 11006999Abstract: The present disclosure relates to devices, systems and methods for evaluating the success of a treatment applied to tissue in a patient, such as a radio frequency ablative treatment used to neuromodulate nerves associated with the renal artery. A system monitors parameters or values generated during the course of a treatment. Feedback provided to an operator is based on the monitored values and relates to an assessment of the likelihood that a completed treatment was technically successful. In other embodiments, parameters or values generated during the course of an incomplete treatment (such as due to high temperature or high impedance conditions) may be evaluated to provide additional instructions or feedback to an operator.Type: GrantFiled: December 13, 2018Date of Patent: May 18, 2021Assignee: Medtronic Ardian Luxembourg S.a.r.l.Inventors: Sowmya Ballakur, Robert J. Beetel, Paul Friedrichs, David Herzfeld, Andrew Wu, Denise Zarins, Mark S. Leung
-
Patent number: 10939958Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: June 10, 2020Date of Patent: March 9, 2021Assignee: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20200398048Abstract: Methods, systems and devices are provided which transmit energy to a body lumen or passageway in the form of pulsed electric fields (PEFs) and in a manner which provides focal therapy. In some embodiments, PEFs are delivered through independent electrically active electrodes of an energy delivery body, typically in a monopolar fashion. Such delivery concentrates the electrical energy over a smaller surface area, resulting in stronger effects than delivery through an electrode extending circumferentially around the lumen or passageway. It also forces the electrical energy to be delivered in a staged regional approach, mitigating the effect of preferential current pathways through the surrounding tissue. Focal delivery of PEFs can provide increased tissue lethality by employing precise timing and sequencing of energy delivery to the electrodes.Type: ApplicationFiled: June 26, 2020Publication date: December 24, 2020Applicant: Galary, Inc.Inventors: William Sanford Krimsky, Denise M. Zarins, Robert J. Beetel, Paul Brian Friedrichs, Roman Turovskiy, Gary L. Long, Robert E. Neal, II, Jonathan Reuben Waldstreicher, Kevin James Taylor
-
Publication number: 20200323586Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: ApplicationFiled: June 10, 2020Publication date: October 15, 2020Applicant: Galary, Inc.Inventors: Jonathan Reuben WALDSTREICHER, William Sanford KRIMSKY, Denise Marie ZARINS, Robert J. BEETEL, III, Paul Brian FRIEDRICHS, Kevin James TAYLOR, Roman TUROVSKIY, Gary L. LONG
-
Patent number: 10702337Abstract: Apparatuses, systems and methods are provided for treating pulmonary tissues via delivery of energy, generally characterized by high voltage pulses, to target tissue using a pulmonary tissue modification system (e.g., an energy delivery catheter system). Example pulmonary tissues include, without limitation, the epithelium (the goblet cells, ciliated pseudostratified columnar epithelial cells, and basal cells), lamina propria, submucosa, submucosal glands, basement membrane, smooth muscle, cartilage, nerves, pathogens resident near or within the tissue, or a combination of any of these. The system may be used to treat a variety of pulmonary diseases or disorders such as or associated with COPD (e.g., chronic bronchitis, emphysema), asthma, interstitial pulmonary fibrosis, cystic fibrosis, bronchiectasis, primary ciliary dyskinesia (PCD), acute bronchitis and/or other pulmonary diseases or disorders.Type: GrantFiled: April 11, 2019Date of Patent: July 7, 2020Assignee: Galary, Inc.Inventors: Jonathan Reuben Waldstreicher, William Sanford Krimsky, Denise Marie Zarins, Robert J. Beetel, III, Paul Brian Friedrichs, Kevin James Taylor, Roman Turovskiy, Gary L. Long
-
Publication number: 20200078609Abstract: Various embodiments are directed to a method of driving an end effector coupled to an ultrasonic drive system of a surgical instrument. The method comprises generating at least one electrical signal. The at least one electrical signal is monitored against a first set of logic conditions. A first response is triggered when the first set of logic conditions is met. A parameter is determined from the at least one electrical signal.Type: ApplicationFiled: June 21, 2019Publication date: March 12, 2020Inventors: Jeffrey D. Messerly, Eitan T. Wiener, Brian T. Noyes, Jeffrey L. Aldridge, James R. Giordano, Robert J. Beetel, III, Daniel J. Abbott, Foster B. Stulen, Matthew C. Miller, Aaron C. Voegele, Jeffrey P. Wiley, Nathan J. Price, Daniel W. Price, Robert L. Koch, Jr.